Financial Performance - The company's operating revenue for Q1 2024 reached ¥771,102,071.99, representing a year-on-year increase of 105.36%[5] - The net profit attributable to shareholders decreased by 15.71% to ¥64,520,522.67 compared to the same period last year[5] - The net profit attributable to shareholders after deducting non-recurring gains and losses increased by 88.42% to ¥41,639,685.18[5] - The diluted earnings per share for the period was ¥0.10, a decrease of 16.67% year-on-year[6] - The company's net profit for Q1 2024 was CNY 64,549,682.52, a decrease of 15.6% compared to CNY 76,524,528.49 in Q1 2023[21] - Operating profit for Q1 2024 was CNY 72,004,023.65, down from CNY 90,166,476.62 in the same period last year, reflecting a decline of 20.2%[21] - Total revenue from sales and services received in Q1 2024 was CNY 487,098,197.19, an increase of 50.5% from CNY 323,776,548.10 in Q1 2023[24] Cash Flow and Expenses - The net cash flow from operating activities was negative at -¥62,494,901.59, a decline of 137.58% year-on-year, primarily due to increased raw material payments[10] - The net cash flow from operating activities for Q1 2024 was negative CNY 62,494,901.59, compared to positive CNY 166,296,938.03 in Q1 2023[25] - The company's total operating expenses for Q1 2024 were CNY 685,578,716.21, compared to CNY 301,861,914.10 in Q1 2023, indicating a significant increase[21] - Research and development expenses increased to CNY 18,359,376.74 in Q1 2024, up 50.5% from CNY 12,172,460.60 in Q1 2023[21] - The company experienced a net cash outflow from investing activities of CNY 166,415,789.58 in Q1 2024, compared to CNY 227,828,820.24 in Q1 2023[25] Assets and Liabilities - The total assets at the end of the reporting period were ¥4,823,445,021.89, up 2.67% from the end of the previous year[6] - The company's total liabilities as of March 31, 2024, were CNY 2,658,029,658.57, slightly up from CNY 2,640,903,712.77 at the end of 2023, showing an increase of about 0.3%[18] - The company's non-current liabilities increased to CNY 974,663,205.84 from CNY 640,933,205.69, indicating a rise of about 52.1%[18] - The total equity attributable to shareholders increased to CNY 2,163,305,996.36 from CNY 2,055,249,269.54, reflecting a growth of approximately 5.3%[18] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 9,318[12] - The top shareholder, Ningbo Dinghong Venture Capital Partnership, holds 65.87% of the shares, totaling 425,490,094 shares[12] Cash and Receivables - The company's cash and cash equivalents decreased to CNY 308,702,680.61 from CNY 434,915,733.99 at the end of 2023, a decline of approximately 29.0%[16] - Accounts receivable increased to CNY 392,552,230.38 from CNY 256,813,915.85, representing a growth of about 53.0%[16] - Inventory decreased to CNY 451,038,242.14 from CNY 500,087,959.76, a reduction of approximately 9.8%[16] - The company reported a total cash and cash equivalents balance of CNY 285,189,924.99 at the end of Q1 2024, compared to CNY 259,759,840.31 at the end of Q1 2023[26] Government Subsidies - The company received government subsidies amounting to ¥23,048,666.66, which are expected to have a sustained impact on profits[9] Borrowings - The company raised CNY 457,450,760.41 in borrowings during Q1 2024, an increase from CNY 312,093,012.00 in Q1 2023[26]

宁波长鸿高分子科技股份有限公司 关于召开 2023 年度暨 2024 年第一季度业绩说明会的 公告 证券代码：605008 证券简称：长鸿高科 公告编号：2024-028 二、 说明会召开的时间、地点 （一） 会议召开时间：2024 年 05 月 28 日 上午 10:00-11:00 会议召开时间：2024 年 05 月 28 日(星期二) 上午 10:00-11:00 会议召开地点：上海证券交易所上证路演中心（网址： 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： https://roadshow.sseinfo.com/） 会议召开方式：上证路演中心网络互动 投资者可于 2024 年 05 月 21 日(星期二) 至 05 月 27 日(星期一)16:00 前 登录上证路演中心网站首页点击"提问预征集"栏目或通过公司邮箱 bh@kygroup.ltd 进行提问。公司将在说明会上对投资者普遍关注的问题进行回 答。 宁波长鸿高分子科技股份有限公司（以下简称"公司"）已于 2024 年 4 月 30 日发布公司 ...

证券代码：605008 证券简称：长鸿高科 公告编号：2024-027 宁波长鸿高分子科技股份有限公司 2024 年第一季度主要经营数据公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 宁波长鸿高分子科技股份有限公司（以下简称"公司"）根据上海证券交易所 《上市公司行业信息披露指引第十三号——化工》的规定，现将 2024 年第一季 度主要经营数据披露如下： 二、主要产品和原材料的价格变动情况 （1）主要产品价格变动情况(不含税) | 主要产品名称 | 2024 年第一季度 | 2023 年第一季度 | 变动比例 | | --- | --- | --- | --- | | | 平均销售单价 | 平均销售单价 | | 特此公告。 主要产品名称 2024 年第一季度 产量（吨） 2024 年第一季度 销量（吨） 2024 年第一季度 营业收入（万元） SBS 17524.531 20789.93 22,823.02 SEBS 7169.34 8138.445 10,629.11 PBT 21831.095 23348.26 18 ...

Financial Performance - The company's operating revenue for 2023 was approximately ¥1.42 billion, a decrease of 40.30% compared to ¥2.37 billion in 2022[24]. - Net profit attributable to shareholders for 2023 was ¥95 million, down 47.35% from ¥180 million in 2022[24]. - Basic earnings per share for 2023 were ¥0.15, a decline of 46.43% from ¥0.28 in 2022[25]. - The company reported a significant increase in cash flow from operating activities, reaching ¥232.93 million, up 214.26% from ¥74.12 million in 2022[24]. - Total assets at the end of 2023 were approximately ¥4.70 billion, an increase of 23.31% from ¥3.81 billion at the end of 2022[24]. - The weighted average return on equity decreased to 4.64% in 2023, down 4.79 percentage points from 9.43% in 2022[25]. - The company experienced a net loss of ¥9.23 million after excluding non-recurring gains and losses, compared to a profit of ¥159.92 million in 2022, marking a 105.77% decline[24]. - The first quarter of 2023 saw a net profit of ¥76.55 million, while the fourth quarter reported a net loss of ¥7.24 million[27]. - The company achieved a consolidated revenue of 1.416 billion yuan in 2023, a decrease of 40.30% year-on-year, and a net profit attributable to shareholders of 95 million yuan, down 47.35% year-on-year, primarily due to high raw material and energy prices, weakened downstream demand, and increased competition in the chemical industry[32]. Dividend Distribution - The company plans to distribute a cash dividend of 3.10 RMB per 10 shares (including tax), amounting to an estimated total of 199,251,264.34 RMB based on the adjusted share count of 642,746,014 shares[6]. - The company has established a profit distribution policy prioritizing cash dividends, with a minimum cash distribution of 10% of the distributable profit in the first three years post-IPO[173]. - In the case of significant capital expenditure, the minimum cash dividend ratio is set at 20% for companies in a growth phase[173]. - The company did not distribute profits for the fiscal year 2022 to support new project construction and long-term development needs[177]. - The cash dividend distribution will be based on the total share capital after deducting repurchased shares, ensuring adjustments if share counts change before the distribution date[177]. - The company emphasizes a stable profit distribution policy, balancing investor returns with sustainable development needs[170]. - The cash dividend policy allows for stock dividends if the company's performance grows rapidly and the stock price does not match the capital scale[175]. - The company declared a cash dividend of CNY 199,251,264.34, which represents 209.72% of the net profit attributable to ordinary shareholders in the consolidated financial statements[180]. - The total amount of dividends, including share repurchases, reached CNY 249,261,619.02, accounting for 262.35% of the net profit attributable to ordinary shareholders[180]. Risk Management - The company has outlined various risks and countermeasures in its management discussion and analysis section, emphasizing the importance of understanding potential challenges[9]. - The company has a comprehensive risk statement regarding future development strategies and financial conditions, advising investors to be aware of investment risks[7]. - The company faces risks from raw material price fluctuations, which significantly impact gross margin[116]. - The company is exposed to risks from macroeconomic fluctuations and potential declines in downstream industry demand[117]. - The company acknowledges increased market competition in the TPES sector, which may affect revenue growth[118]. - The company recognizes the growing market for PBAT, a biodegradable material, but warns of potential oversupply risks affecting industry profit margins[119]. Corporate Governance - The company is committed to transparency, with all board members present at the board meeting to ensure the integrity of the annual report[4]. - The company emphasizes improving corporate governance and investor relations, enhancing transparency in information disclosure[36]. - The company held 7 shareholder meetings and 13 board meetings during the reporting period, ensuring compliance with legal and regulatory requirements[123]. - All resolutions proposed during the shareholder meetings were approved, with no rejected proposals reported[126]. - The total number of shares held by the chairman, Tao Chunfeng, remained unchanged at 14,000,000 shares throughout the year[128]. - The total remuneration for the board members and senior management during the reporting period amounted to 341.45 million yuan[130]. - The company has not reported any changes in shareholding for the vice chairman, Fu Jianli, and other directors during the year[128]. - The company’s management team has remained stable, with no significant changes in key positions reported[130]. - The company has undergone changes in supervisory roles to ensure effective governance[140]. Environmental Responsibility - The company invested CNY 1,830,000 in environmental protection during the reporting period[185]. - The company was listed as a key pollutant discharge unit by the Ningbo Ecological Environment Bureau, with wastewater and air emissions monitored and reported within standard limits[186]. - The company has a 100% compliance rate in hazardous waste disposal, with contracts signed with qualified disposal units[187]. - The company has installed an online monitoring system for wastewater discharge, with no exceedances reported during the year[186]. - Guangxi Changhong has established a wastewater treatment facility with a capacity of 25 tons per hour, utilizing multiple treatment processes, and currently operates stably with all discharge quality indicators meeting standards[195]. - The company has developed a self-monitoring plan for environmental monitoring, with regular inspections and compliance results for wastewater, waste gas, and noise[200]. - The company has established a comprehensive air pollution control system, including a gas thermal medium furnace and various dust removal measures[195]. Research and Development - The company has applied for two invention patents related to PBAT and PBT production methods, indicating a strong focus on R&D[85]. - The total R&D expenditure for the period was CNY 55,116,040.31, representing 3.89% of total revenue[60]. - The company is investing $50 million in R&D for new technologies aimed at enhancing user experience[131]. - The company has initiated the development of new technologies, with an R&D budget increase of 25% for the upcoming fiscal year[144]. Market Position and Strategy - The company is optimistic about the future of the biodegradable plastics industry and plans to enhance its integrated supply chain to lower production costs and improve competitiveness[38]. - The carbon black market is expected to grow due to increasing demand from the automotive sector and the implementation of energy-saving and emission-reduction policies[39]. - The company is focusing on high-end markets with its vertical mills, which have lower production costs and higher profit margins compared to other types of equipment[94]. - The company is considering strategic acquisitions to bolster its market position, with a budget of $100 million allocated for potential deals[131]. - The company is focusing on market expansion and new product development as part of its strategic initiatives[135].

证券代码：605008 证券简称：长鸿高科 公告编号：2024-013 宁波长鸿高分子科技股份有限公司 关于为控股子公司提供银行授信担保的进展公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 被担保人名称:浙江长鸿生物材料有限公司（以下简称"长鸿生物"或"子 公司"） 本次担保金额及已实际为其提供的担保余额:宁波长鸿高分子科技股份 有限公司（以下简称"公司"或"长鸿高科"）本次为长鸿生物担保金额为人民 币 2,000 万元。截至目前，公司已实际为其提供的担保余额为 7.11 亿元。 一、担保情况概述 （一）担保基本情况 近日，公司与宁波通商银行股份有限公司绍兴分行签署了《最高额保证担保 合同》，为债务人长鸿生物提供 2,000 万元人民币的最高额保证担保。 告编号：2023-028）、《2022 年年度股东大会决议公告》（公告编号：2023-037）。 本次担保事项在上述授权范围内，无需另行召开董事会及股东大会审议。 二、被担保人基本情况 1、浙江长鸿生物材料有限公司 企业类别：有限责任公司（非自然人投资或 ...

证券代码：605008 证券简称：长鸿高科 公告编号：2024-012 关于获得政府补助的公告 宁波长鸿高分子科技股份有限公司 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 一、获取政府补助的基本情况 宁波长鸿高分子科技股份有限公司（以下简称"长鸿高科"）下属全资子公 司浙江长鸿生物材料有限公司（以下简称"长鸿生物"）于 2024 年 3 月 18 日收 到政府补助人民币 19,169,900 元，占公司 2022 年度经审计归属于上市公司股东 净利润绝对值的比例为 10.62%。具体明细如下： 单位：元 币种：人民币 上述收到的政府补助将对公司利润产生积极影响，具体影响金额以会计师事 务所年度审计确认后的结果为准。敬请广大投资者注意投资风险。 特此公告。 1 获得补助金额：人民币 19,169,900 元（数据未经审计）。 对当期损益的影响：根据《企业会计准则第 16 号——政府补助》的相关规 定，上述收到的政府补助属于与收益类相关的政府补助，将对公司利润产生 积极影响，具体影响金额以会计师事务所年度审计确 ...

甬兴证券有限公司（以下简称"甬兴证券"、"保荐人"）作为宁波长鸿高分子科 技股份有限公司（以下简称"长鸿高科"、"公司"）2022年度向特定对象发行A股股 票的保荐人，根据《证券发行上市保荐业务管理办法》《上海证券交易所股票上 市规则（2023年8月修订）》《上市公司监管指引第2号——上市公司募集资金管 理和使用的监管要求（2022年修订）》《上海证券交易所上市公司自律监管指引 第1号——规范运作（2023年12月修订）》等相关法律、法规和规范性文件的规 定，就公司使用募集资金置换已支付发行费用的自筹资金事项进行了核查，并出 具核查意见如下： 2023年8月1日，中国证监会出具了《关于同意宁波长鸿高分子科技股份有 限公司向特定对象发行股票注册的批复》（证监许可[2023]1708号），同意公 司本次向特定对象发行股票的注册申请。公司本次向特定对象发行股票 3,582,000股，发行价格为13.96元/股，募集资金总额为人民币50,004,720元，扣除 发行费用（不含增值税）人民币8,259,983.02元，实际募集资金净额为人民币 41,744,736.98元。公司本次向特定对象发行股票募集资金已于2024 ...

一、募集资金基本情况 2023年8月1日，中国证监会出具了《关于同意宁波长鸿高分子科技股份有 限公司向特定对象发行股票注册的批复》（证监许可[2023]1708号），同意公司 本次向特定对象发行股票的注册申请。公司本次向特定对象发行股票3,582,000 股，发行价格为13.96元/股，募集资金总额为人民币50,004,720元，扣除发行费用 （ 不 含 增 值 税 ） 人 民 币 8,259,983.02 元 ， 实 际 募 集 资 金 净 额 为 人民币 41,744,736.98元。公司本次向特定对象发行股票募集资金已于2024年2月1日划至 公司指定账户，立信中联会计师事务所（特殊普通合伙）对募集资金的到位情况 进行了审验，并于2024年2月2日出具了《宁波长鸿高分子科技股份有限公司验资 报告》（立信中联验字[2024]D-0003号）。 证券代码：605008 证券简称：长鸿高科 公告编号：2024-011 宁波长鸿高分子科技股份有限公司 关于使用募集资金置换已支付发行费用的自筹资金 的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性 ...

宁波长鸿高分子科技股份有限公司 公司章程 | 第一章 | 总则 2 | | --- | --- | | 第二章 | 经营宗旨和范围 3 | | 第三章 | 股份 3 | | 第一节 | 股份发行 3 | | 第二节 | 股份增减和回购 4 | | 第三节 | 股份转让 6 | | 第四章 | 股东和股东大会 7 | | 第一节 | 股东 7 | | 第二节 | 股东大会的一般规定 9 | | 第三节 | 股东大会的召集 12 | | 第四节 | 股东大会的提案与通知 13 | | 第五节 | 股东大会的召开 15 | | 第六节 | 股东大会的表决和决议 18 | | 第五章 | 董事会 23 | | 第一节 | 董事 23 | | 第二节 | 董事会 26 | | 第六章 | 总经理及其他高级管理人员 33 | | 第七章 | 监事会 35 | | 第一节 | 监事 35 | | 第二节 | 监事会 35 | | 第八章 | 财务会计制度、利润分配和审计 37 | | 第一节 | 财务会计制度 37 | | 第二节 | 内部审计 40 | | 第三节 | 会计师事务所的聘任 40 | | 第九章 | 通知和 ...

关于宁波长鸿高分子科技股份有限公司 以自筹资金预先支付发行费用的 专 项 鉴 证 报 告 -- 立信中联专审字[2024]D-0036 号 立信中联会计师事务所(特殊普通合伙) LixinZhonglian CPAs (SPECIAL GENERAL PARTNERSHIP) 您可使用手机"扫一扫"或进入"注册会计师行业统一监管平台（http://zc.cnof.gov.cn）"进行 您可使用手机"扫一扫"或进入"注册会计师行业统一监管平台（http://zc.cnof.gov.cn）" 进行 | 1 1 la | | --- | | Car 1 | | | 专项鉴证报告 | 1-2 | | --- | --- | --- | | 11 | 专项说明 | - 1-2 | 立信中联会计师事务所(特殊普通合伙) LixinZhonglian CPAs (SPECIAL GENERAL PARTNERSHIP) 关于宁波长鸿高分子科技股份有限公司 以自筹资金预先支付发行费用的 专 项 鉴 证 报 告 立信中联专审字[2024]D-0036 号 宁波长鸿高分子科技股份有限公司全体股东: 我们接受委托,对后附的宁波长鸿 ...